Day: January 7, 2026

Results and Investor Q&A to Be Released in Lieu of Investor Presentation Detroit, Michigan, Jan. 07, 2026 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), a global leader in AI-driven security and productivity solutions, today announced its fiscal Q3 results are expected to be filed on January 15, 2026. Concurrently, a comprehensive investor interview featuring CEO/CTO and founder Steve Reinharz will be published that will review Q3 highlights as well as directly addressing questions raised by shareholders and market observers. The interview, conducted by SmallCapVoice, is to be released alongside the Company’s Q3 financial filing, departs from traditional executive communications by intentionally including questions that many public company executives generally do not discuss...

Also Updates Solana Holdings, Repurchases Shares TAMPA, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) — Upexi, Inc. (NASDAQ: UPXI), a leading Solana-focused digital asset treasury company and consumer brands owner, announced that it will implement a risk-adjusted high yield strategy designed to materially enhance Solana treasury returns in 2026. Upexi does not expect the implementation to cause any disruption to its Solana treasury operations. The Company believes this strategic shift will allow it to pursue improved yields in a disciplined and prudent manner, increasing operational flexibility, and strengthening alignment between treasury activities and broader corporate objectives. Upexi updated its Solana holdings, which now stand at 2,174,583 SOL as of January 5, 2026. This represents a 3.2% increase from the 2,106,989 SOL as of October...

– Common warts affects approximately 22 million patients in the United States alone, and there are no FDA approved prescription therapies for what is believed to be a multibillion-dollar market opportunity– – Verrica has global rights to YCANTH for all indications in all territories outside of Japan – WEST CHESTER, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that the first patient was dosed in December 2025 in the global Phase 3 program evaluating YCANTH (VP-102) for the treatment of common warts. “The dosing of the first patient in the global Phase 3 program in common warts represents an important clinical milestone for our label expansion strategy...

Agreement Finalized and Solution Deployed in 2025; Delivering New Tax-Efficient Non-Gaming Revenue to WarHorse Gaming Properties NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — WarHorse Gaming announced today it has deployed Context Networks’ Contextual Promotions Media Network™ (CPMN™) powered by Mobiquity Technologies’ (OTCQB: MOBQ) next-generation advertising and data intelligence solutions across two WarHorse Casino properties in Nebraska. The agreement was sold through Context Networks’ established reseller, NRT Technology. The deployment brings Context Networks’ full-stack, end-to-end advertising and analytics platform into gaming environments, enabling WarHorse Gaming to operate as a digital publisher while creating incremental, tax-efficient, non-gaming revenue. Powered by Mobiquity’s advanced advertising technology,...

DURANGO, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, or “RMCF”), America’s Chocolatier™ and a leading franchiser of a premium chocolate and confectionary retail store concept, will host a conference call on Wednesday, January 14, 2026 at 9:00 a.m. Eastern time to discuss its fiscal third quarter 2026 results. The Company’s results will be reported in a press release prior to the call. The RMCF management team will host the conference call, followed by a question-and-answer period. Attendees are invited to submit questions ahead of the call by emailing the Company’s investor relations team at RMCF@elevate-ir.com. The conference call details are as follows: Date: Wednesday, January 14, 2026Time: 9:00 a.m. Eastern timeDial-in registration link: hereLive...

Initial design and prototype order valued at approximately $1.2 million Integration of OSS hardware into prime contractor system further validates OSS capabilities for next-generation 360-degree vision and sensor processing solutions ESCONDIDO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced it has received an approximately $1.2 million pre-production order from a new U.S. defense prime contractor for the design, development, and delivery of ruggedized integrated compute and visualization systems for U.S. Army combat vehicles. “This engagement with a new, top-tier U.S. defense prime contractor marks a meaningful milestone for OSS,”...

ATLANTA, Jan. 07, 2026 (GLOBE NEWSWIRE) — Gray Media, Inc. has named Kristy Santiago as the next General Manager of KFVS (CBS and CW) in Cape Girardeau, Missouri and WQWQ-LD (Telemundo) in Paducah, Kentucky.Kristy brings decades of experience in television station management and sales operations. Throughout her career, she has overseen operations for multiple networks across several markets. She was instrumental in launching a number of Telemundo, CW and FOX affiliations. Most recently, Kristy served as General Manager of KION (CBS), KMUV (Telemundo), KCBA (CW) in Monterey, CA. She also served in leadership positions in Grand Junction, CO and Palm Springs, CA. In addition to her professional accomplishments, Kristy has been active in both industry and community organizations. She has served on Boards including the California...

MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) — Captivision Inc. (“Captivision” or the “Company”) (Nasdaq: CAPT), today announced that it has been informed that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request to extend the deadline for regaining compliance with the Nasdaq Listing Rules, subject to certain conditions related to the Company’s ongoing efforts to regain compliance with Nasdaq Listing Rule 5250(c)(1) (the “Periodic Filing Rule”). Pursuant to the Panel’s decision, the Company must demonstrate compliance with the Periodic Filing Rule on or before March 31, 2026, with respect to 2024 fiscal year audited financial results, and April 17, 2026, with respect to reporting first half 2025 financial results (the “Extension Periods”). The Company today also announced that it received a letter...

David Zaccardelli, Pharm.D. joins Board as Chair Rita Jain, M.D., joins Board as an Independent Director MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced the appointment of David Zaccardelli, Pharm.D. to its Board of Directors as Chair of the Board and the appointment of Rita Jain, M.D., as an independent director, both effective immediately. “We are excited to welcome Dr. David Zaccardelli and Dr. Rita Jain to our Board of Directors. I, along with the rest of our Board, am confident that David and Rita will make a significant impact on SAB BIO,” said Samuel J. Reich, CEO, SAB BIO. Mr. Reich continued, “David is an esteemed...